Revolution Medicines, Inc. is 6.3x more valuable than CG Oncology, Inc. by market capitalization ($30.65 B vs $4.84 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CGON | RVMD |
|---|---|---|
| Market cap | $4.84 B | $30.65 B |
| US-listed rank | #1405 | #454 |
| Revenue (latest FY) | - | $0.00 |
| Net income (latest FY) | -$161.00M | -$1.13B |
| SEC filings | 189 | 782 |
Revolution Medicines, Inc. is 6.3x more valuable than CG Oncology, Inc. by market capitalization ($30.65 B vs $4.84 B).
Full pages: CG Oncology, Inc. and Revolution Medicines, Inc., or browse the full rankings.